Corporate Governance

Shenzhen – September 15, 2026 -- TCL has been named to TIME's World's Best Companies for 2026, a ranking compiled with Statista from an independent survey of 200,000 employees across more than 50 countries.

TCL Technology and TCL Industries post double-digit revenue growth in 2025

TCL Technology recorded revenue of approximately US$27 billion in 2025, up 11.7% year on year, while TCL Industries reported revenue of roughly US$24.9 billion, an increase of 13.8%. Overseas revenue exceeded US$24.93 billion, with average annual growth of more than 18.3% over the past five years.

Global footprint spans manufacturing hubs in five countries and 160-plus markets

TCL operates manufacturing and R&D facilities across China, Vietnam, Poland, Mexico and Brazil, serving customers in more than 160 countries and regions.

Washington – September 15, 2026 -- National Real Estate Advisors will replace founder and CEO Jeffrey Kanne with Kevin Verdi, its Executive Vice President and Chief Investment Officer, effective January 2027, the institutional investment manager announced.

Kanne exits after more than 25 years building the firm into an institutional real estate platform

Kanne, who founded National in 2000, will retire from the CEO role after more than a quarter-century at the helm, during which the firm grew into an investment manager serving U.S. and international institutional investors. He will remain with National as a Special Advisor following the leadership change.

Singapore – September 15, 2026 -- Mega Matrix Inc. (NYSE American: MPU) will consolidate its Class A ordinary shares on a 1-for-20 basis effective 4:05 p.m. New York time on September 15, 2026, cutting its outstanding Class A share count from 62,492,148 to approximately 3,124,608.

Reverse split aims to lift trading price above NYSE American thresholds

The company said the consolidation is primarily intended to increase its per-share trading price to maintain its listing on NYSE American. Shares will begin trading on a post-consolidation adjusted basis when the market opens September 16, 2026, continuing under the ticker "MPU" with a new CUSIP number, G6005C116.

Palo Alto, Calif. – September 15, 2026 -- CogniCor, an intelligence and orchestration platform for registered investment advisors, has expanded its Advisory Board with six new industry figures to accelerate its push into firm-wide AI adoption across wealth management.

Beacon Pointe co-founder joins board overseeing $62 billion RIA

Shannon Eusey, Chairman and Co-Founder of Beacon Pointe Advisors, one of the largest RIAs in the country with more than $62 billion in assets under advisement, joined the board as both a CogniCor customer and RIA operator.

Monroe, Ohio – September 15, 2026 -- CSafe, a provider of temperature-controlled shipping solutions for the life sciences industry, has appointed Will Romanowicz as Chief Legal Officer, effective September 9, 2026.

Romanowicz Brings Decade-Plus of Regulated-Industry Legal Experience

Romanowicz joins with more than ten years of legal, governance, and commercial leadership across FDA-regulated sectors, including biotech, agribusiness, SaaS, food & beverage, and supplements. He has worked with both large global public companies and late-stage startups.

Most recently, he held a combined legal and commercial role leading a cross-functional team responsible for legal affairs, government affairs, and external communications. Earlier in his career, he practiced corporate law, advising companies on governance, restructuring, and complex transactions.

Chicago – September 15, 2026 -- CME Group has appointed Jack Tobin as its next Chief Financial Officer, effective March 2027, when current President & CFO Lynne Fitzpatrick becomes Chief Executive Officer.

Tobin moves to Deputy CFO in November 2026 ahead of formal handover

Tobin, CME Group's Chief Accounting Officer since 2015, will step into the Deputy Chief Financial Officer role in November 2026 to manage the transition before assuming the CFO title. He will continue reporting to Fitzpatrick and brings more than 35 years of financial experience, including accounting, corporate development and finance oversight at CME Group since joining in 2002. He previously worked as a principal consultant at PricewaterhouseCoopers and holds bachelor's and master's degrees from DePaul University.

Houston – September 15, 2026 -- ImmunoGenesis has appointed Reza Mazhari, Ph.D., and Mike Davis to its Board of Directors as the clinical-stage biotech advances its lead immunotherapy candidate toward key data readouts in mid-2027.

ImmunoGenesis has initiated a Phase 1b trial for lead asset IMGS-001

IMGS-001, a cytotoxic checkpoint inhibitor targeting PD-L1 and PD-L2, is being studied for immune-excluded tumors, a category that accounts for more than half of all cancers. James Barlow, President and CEO of ImmunoGenesis, said the new board members will help shape pipeline, partnering and fundraising strategy for the company's next growth phase.